The efficacy and side effects of interferon alpha 2a (Roferon) on chronic hepatitis B virus infection in Turkish children

Hepatology Research

Volumn 15, Issue 1, 1999, Pages 1-9

  Kansu, Aydan ^a   Altuntaş, Buket ^a   Doganci, Tümay ^a   Gazi Kalayci, Ayhan ^a   Girgin, Nurten ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Children; Chronic hepatitis B; Interferon alpha

Indexed keywords

ALANINE AMINOTRANSFERASE; RECOMBINANT ALPHA2A INTERFERON; THYROID ANTIBODY;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHILD; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FLU LIKE SYNDROME; HEPATITIS B; HUMAN; MALE; PRIORITY JOURNAL; SEIZURE; SEROCONVERSION; THYROID FUNCTION; TREATMENT OUTCOME;

EID: 0033023634     PISSN: 09284346     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1386-6346(98)00033-3     Document Type: Article

References (27)

1. Ruiz-Moreno M., Camps T., Aguado J.G., Porres J.C., Oliva H., Bartolome J., Carreno V. Serological and histological follow up of chronic hepatitis B infection. Arch Dis Child. 64:1989;1165-1169.
2. Hoofnagle J.H., Peters M., Mullen K.D.et al. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology. 95:1988;1318-1325.
3. Barbera C., Bortolotti F., Crivellaro C.et al. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B. Hepatology. 20:1994;287-290.
4. Sokal E.M., Wirth S., Goyens P., Depreterne A., Cornu C. Interferon alpha-2b therapy in children with chronic hepatitis B. Gut. 34(Suppl. 2):1993;S87-S90.
5. Lai C.L., Lin H.J., Lau J.Y.N. Effect of recombinant alpha-2 interferon with or without prednisone in Chinese HBsAg carrier children. Q J Med. 286:1991;155-163.
6. Sonnenblick M., Rosin A. Cardiotoxicity and interferon. A review of 44 cases. Chest. 99:1991;557-561.
7. Mattson K., Niiranen A., Iivanainen M.et al. Neurotoxicity of interferon (letter). Cancer Treat Rep. 67:1983;958-961.
8. Guyer D.R., Tiedeman J., Yannuzzi L.A.et al. Interferon-associated retinopathy. Arch Ophthalmol. 111:1993;350-356.
9. Degertekin H., Kestellioglu F. The prevalence of HBsAg in healthy people and several liver diseases in Turkey. Asian Med J. 29:1986;125-127.
10. Chomcynski P., Sacchi N. Single step method of RNA isolation by acid-guanidiumthiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1984;156-159.
11. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature. 339:1989;237-238.
12. Knodell R.G., Ishak K.G., Black W.C. Formulation and application of a numerical scoring system for assessing histological activity in a symptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
13. Alter M.J., Mast E.E. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am. 23:1994;437-455.
14. Bellentani S., Tiribelli C., Saccoccio G., Sodde M., Fratti N., De Martin C., Cristianini G. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology. 20:1994;1442-1449.
15. McMahon B.J., Alward W.L., Hall D.B., Heyward W.L., Bender T.R., Francis D.P., Maynard J.E. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis. 151:1985;599-603.
16. Utili R., Sagnelli E., Galanti B.et al. Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study. Am J Gastroenterol. 86:1991;327-330.
17. Lok A.S. Alpha interferon therapy for chronic hepatitis B virus infection in children and Oriental patients. J Gastroenterol Hepatol. 6(Suppl 1):1991;15-17.
18. Ruiz-Moreno M., Rua M.J., Molina J., Moraleda G., Moreno A., Garcia-Aguado J., Carreno V. Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B. Hepatology. 13:1991;1035-1039.
19. Bruguera M., Amat L., Garcia O.et al. Treatment of chronic hepatitis B in children with recombinant alfa interferon. Different response according to age at infection. J Clin Gastroenterol. 17:1993;296-299.
20. Jonas M.M. Interferon alpha for viral hepatitis. J Ped Gastroenterol Nutr. 23:1996;93-106.
21. Perrillo R.P., Schiff E.R., Davis G.L.et al. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. New Engl J Med. 323:1990;295-301.
22. Hoofnagle J.H., Di Bisceglie A.M. The treatment of chronic viral hepatitis. Drug Ther. 336:1997;347-356.
23. Burma P., Karlsson F.A., Oberg K., Alm G. Autoimmune thyroid disease in interferon treated patients. Lancet. 2:1985;100-101.
24. Lisker-Melman M., Di Bisceglie A.M., Usala S.J., Weintraub B., Murray L.M., Hoofnagle J.H. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterology. 102:1992;2155-2160.
25. Janssen H.L., Berk L., Vermeulen M., Schalm S.W. Seizures associated with low-dose alpha-interferon (letter). Lancet. 336(8730):1990;1580.
26. Miller V.S., Zwiener R.J., Fielman B.A. Interferon-associated refractory status epilepticus. Pediatrics. 93:1994;511-512.
27. Mitsuyama Y., Hashiguchi H., Murayama T., Koono M., Nishi S. An autopsied case of interferon encephalopathy. Jpn J Psychiatry Neurol. 46:1992;741-748.